Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

NCT07260877 is registered in ClinicalTrials.gov with Ventus Therapeutics U.S., Inc. as lead sponsor.

NCT NCT07260877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07260877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
Lead sponsor
Ventus Therapeutics U.S., Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
December 3, 2025
Completion date
March 31, 2027
Enrollment
24 (estimated)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

cle, cutaneous lupus erythematosus (cle), sle, sle (systemic lupus), systemic lupus erythematosus